000119237 001__ 119237
000119237 005__ 20240228145429.0
000119237 0247_ $$2doi$$a10.1177/0192623316670781
000119237 0247_ $$2pmid$$apmid:27708198
000119237 0247_ $$2ISSN$$a0094-1824
000119237 0247_ $$2ISSN$$a0192-6233
000119237 0247_ $$2ISSN$$a1533-1601
000119237 037__ $$aDKFZ-2017-00027
000119237 041__ $$aeng
000119237 082__ $$a610
000119237 1001_ $$aHarrill, Alison H$$b0
000119237 245__ $$aA Synopsis of the 'Influence of Epigenetics, Genetics, and Immunology' Session Part A at the 35th Annual Society of Toxicologic Pathology Symposium.
000119237 260__ $$aThousand Oaks, Calif.$$bSage$$c2017
000119237 3367_ $$2DRIVER$$aarticle
000119237 3367_ $$2DataCite$$aOutput Types/Journal article
000119237 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1511334451_28942$$xReview Article
000119237 3367_ $$2BibTeX$$aARTICLE
000119237 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000119237 3367_ $$00$$2EndNote$$aJournal Article
000119237 520__ $$aThe overarching theme of the 2016 Society of Toxicology Pathology's Annual Symposium was 'The Basis and Relevance of Variation in Toxicologic Responses.' Session 4 focused on genetic variation as a potential source for variability in toxicologic responses within nonclinical toxicity studies and further explored how knowledge of genetic traits might enable targeted prospective and retrospective studies in drug development and human health risk assessment. In this session, the influence of both genetic sequence variation and epigenetic modifications on toxicologic responses and their implications for understanding risk were explored. In this overview, the presentations in this session will be summarized, with a goal of exploring the ramifications of genetic and epigenetic variability within and across species for toxicity studies and disseminating information regarding novel tools to harness this variability to advance understanding of toxicologic responses across populations.
000119237 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000119237 588__ $$aDataset connected to CrossRef, PubMed,
000119237 7001_ $$aMoggs, Jonathan G$$b1
000119237 7001_ $$aAdkins, Karissa K$$b2
000119237 7001_ $$0P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b$$aAugustin, Hellmut$$b3$$udkfz
000119237 7001_ $$aJohnson, Robert C$$b4
000119237 7001_ $$aLeach, Michael W$$b5
000119237 773__ $$0PERI:(DE-600)2056753-4$$a10.1177/0192623316670781$$gVol. 45, no. 1, p. 114 - 118$$n1$$p114 - 118$$tToxicologic pathology$$v45$$x1533-1601$$y2017
000119237 909CO $$ooai:inrepo02.dkfz.de:119237$$pVDB
000119237 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000119237 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000119237 9141_ $$y2017
000119237 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000119237 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000119237 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bTOXICOL PATHOL : 2015
000119237 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000119237 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000119237 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000119237 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000119237 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000119237 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000119237 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000119237 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000119237 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000119237 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000119237 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000119237 9201_ $$0I:(DE-He78)A190-20160331$$kA190$$lVaskuläre Onkologie und Metastasierung$$x0
000119237 980__ $$ajournal
000119237 980__ $$aVDB
000119237 980__ $$aI:(DE-He78)A190-20160331
000119237 980__ $$aUNRESTRICTED